(Q43781265)

26 November 2017

title

Delay of simple reaction time after levodopa intake (English)

1 reference

26 November 2017

1 reference

Müller T

1

1 reference

26 November 2017

Benz S

series ordinal

2

1 reference

26 November 2017

Börnke C

series ordinal

3

1 reference

26 November 2017

publication date

1 November 2001

1 reference

26 November 2017

published in

Clinical Neurophysiology

1 reference

26 November 2017

volume

112

1 reference

26 November 2017

issue

11

1 reference

26 November 2017

page(s)

2133-2137

1 reference

Yawning: neurochemistry, physiology and pathology

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900653-8

7 January 2021

Motor response to acute dopaminergic challenge with apomorphine and levodopa in Parkinson's disease: implications for the pathogenesis of the on-off phenomenon

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900653-8

7 January 2021

Reaction time in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900653-8

7 January 2021

Sleep attacks and Parkinson's disease treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900653-8

7 January 2021

Pharmacologic strategies for augmenting cognitive performance in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900653-8

7 January 2021

Sleep episodes in Parkinson's disease: a wake-up call.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900653-8

7 January 2021

Motor and cognitive performances of parkinsonian patients in the on and off phases of the disease

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900653-8

7 January 2021

Distribution of histamine H3-receptor binding in the normal human basal ganglia: comparison with Huntington's and Parkinson's disease cases

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900653-8

7 January 2021

Yawning as an aura for an L-dopa-induced "on" in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900653-8

7 January 2021

Differences in the motor response to apomorphine between untreated and fluctuating patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900653-8

7 January 2021

Abnormal refractoriness in patients with Parkinson's disease after brief withdrawal of levodopa treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900653-8

7 January 2021

Fluctuations in plasma dopamine level impair memory in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900653-8

7 January 2021

Dose-dependent memory impairment in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900653-8

7 January 2021

Challenge tests to predict the dopaminergic response in untreated Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900653-8

7 January 2021

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900653-8

7 January 2021

The pharmacology of memory.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900653-8

7 January 2021

Simple and choice reaction time and the use of advance information for motor preparation in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900653-8

7 January 2021

The effect of withdrawal of dopaminergic medication on simple and choice reaction time and the use of advance information in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900653-8

7 January 2021

A comparative study of simple and choice reaction time in Parkinson's, Huntington's and cerebellar disease

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900653-8

7 January 2021

Cognitive components of reaction time in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900653-8

7 January 2021

Acute effects of levodopa on neuropsychological performance in stable and fluctuating Parkinson's disease patients at different levodopa plasma levels.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900653-8

7 January 2021

The neurobiological basis of movement initiation

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900653-8

7 January 2021

Core assessment program for intracerebral transplantations (CAPIT)

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900653-8

7 January 2021

Evidence for histaminergic arousal mechanisms in the hypothalamus of cat.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900653-8

7 January 2021

"On-off" effects in patients with Parkinson's disease on chronic levodopa therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900653-8

7 January 2021

A study of tolerance to apomorphine

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900653-8

7 January 2021

Reaction time and movement velocity abnormalities in Parkinson's disease under different task conditions

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900653-8

7 January 2021

Tolcapone increases maximum concentration of levodopa

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900653-8

7 January 2021

Dopamine D2 mechanisms in canine narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900653-8

7 January 2021

Motor response to repeated dopaminergic stimulation in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900653-8

7 January 2021

Domperidone and Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900653-8

7 January 2021

Cognitive slowing in Parkinson's disease fails to respond to levodopa treatment: the 15-objects test

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900653-8

7 January 2021

Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions?

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900653-8

7 January 2021

Sleep attacks in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900653-8

7 January 2021

Dopaminergic induced changes in cognitive and motor processing in Parkinson's disease: an electrophysiological investigation

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900653-8

7 January 2021

Dopaminergic effects on simple and choice reaction time performance in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900653-8

7 January 2021

Movement amplitude choice reaction time performance in Parkinson's disease may be independent of dopaminergic status

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900653-8

7 January 2021

Gastrointestinal dysfunction in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900653-8

7 January 2021

Cognition and the basal ganglia. Separating mental and motor components of performance in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900653-8

7 January 2021

Preparation of manual movements in hemiparkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900653-8

7 January 2021

Effect of practice on performance of a skilled motor task in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900653-8

7 January 2021

Effects of chronic levodopa and pergolide treatment on cortical excitability in patients with Parkinson's disease: a transcranial magnetic stimulation study

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900653-8

7 January 2021

A meta-analysis on cognitive slowing in Parkinson's disease: are simple and choice reaction times differentially impaired?

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900653-8

7 January 2021

Dopaminergic modulation of cholinergic responses in rat medial prefrontal cortex: an electrophysiological study

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900653-8

7 January 2021

Usefulness of movement time in the assessment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900653-8

7 January 2021

Short-term levodopa test assessed by movement time accurately predicts dopaminergic responsiveness in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1388-2457%2801%2900653-8

7 January 2021

10.1016/S1388-2457(01)00653-8

Identifiers

DOI

1 reference

26 November 2017

1 reference